Related Experiment Video
Updated: Aug 29, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
A small-molecule inhibitor and degrader of the RNF5 ubiquitin ligase
Jingjing Ruan1,2, Dongdong Liang3, Wenjing Yan1
1Center for Biomedical Engineering and Technology, Department of Physiology, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201.
Abstract:
RNF5 E3 ubiquitin ligase has multiple biological roles and has been linked to the development of severe diseases such as cystic fibrosis, acute myeloid leukemia, and certain viral infections, emphasizing the importance of discovering small-molecule RNF5 modulators for research and drug development. The present study describes the synthesis of a new benzo[b]thiophene derivative, FX12, that acts as a selective small-molecule inhibitor and degrader of RNF5. We initially identified the previously reported STAT3 inhibitor, Stattic, as an inhibitor of dislocation of misfolded proteins from the endoplasmic reticulum (ER) lumen to the cytosol in ER-associated degradation. A concise structure-activity relationship campaign (SAR) around the Stattic chemotype led to the synthesis of FX12, which has diminished activity in inhibition of STAT3 activation and retains dislocation inhibitory activity. FX12 binds to RNF5 and inhibits its E3 activity in vitro as well as promoting proteasomal degradation of RNF5 in cells. RNF5 as a molecular target for FX12 was supported by the facts that FX12 requires RNF5 to inhibit dislocation and negatively regulates RNF5 function. Thus, this study developed a small-molecule inhibitor and degrader of the RNF5 ubiquitin ligase, providing a chemical biology tool for RNF5 research and therapeutic development.
Insights
Researchers developed FX12, a novel small molecule that inhibits and degrades RNF5 E3 ubiquitin ligase. This compound serves as a valuable tool for studying RNF5
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- RNF5 E3 ubiquitin ligase plays critical roles in various biological processes.
- Dysregulation of RNF5 is implicated in severe diseases like cystic fibrosis, acute myeloid leukemia, and viral infections.
- Targeting RNF5 with small molecules is crucial for research and therapeutic development.
Purpose of the Study:
- To synthesize and characterize a novel small-molecule inhibitor and degrader of RNF5.
- To investigate the mechanism of action of the new compound, FX12.
- To provide a chemical biology tool for RNF5 research.
Main Methods:
- Structure-activity relationship (SAR) study based on the STAT3 inhibitor Stattic.
- Synthesis of benzo[b]thiophene derivative FX12.
- In vitro enzymatic assays to assess E3 ligase activity.
- Cell-based assays to evaluate protein degradation and functional effects.
Main Results:
- FX12 selectively inhibits RNF5 E3 ubiquitin ligase activity in vitro.
- FX12 promotes proteasomal degradation of RNF5 in cellular models.
- FX12 inhibits dislocation of misfolded proteins from the ER lumen, dependent on RNF5.
- FX12 demonstrates diminished activity against STAT3 activation compared to Stattic.
Conclusions:
- FX12 is a potent and selective small-molecule inhibitor and degrader of RNF5.
- FX12 functions as a valuable chemical probe for studying RNF5 biology.
- The developed compound holds potential for therapeutic development targeting RNF5-related diseases.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Export of Misfolded Proteins out of the ER

